University of Colorado Denver.
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Arthritis Rheumatol. 2023 Apr;75(4):507-516. doi: 10.1002/art.42370. Epub 2023 Feb 22.
Prevotella copri (P copri), a gut commensal, has been reported to be an immune-relevant organism in individuals with rheumatoid arthritis (RA). This study sought to evaluate anti-P copri (anti-Pc) antibody responses in our participant cohorts and to determine when in the natural history of RA such responses develop.
We analyzed serum levels of immunoglobulin A (IgA) and IgG antibodies from a 27-kd protein of P copri (anti-Pc-p27), an immunogenic P copri protein, in study participants at risk of developing RA, participants who transitioned to RA, participants with early RA (<1 year of disease), and participants with established RA, with comparisons made to their matched controls. We also evaluated anti-Pc-p27 antibody levels in individuals stratified by RA-related autoantibody status.
Overall, participants with RA had significantly higher IgA anti-Pc-p27 antibody levels and trended toward higher IgG anti-Pc-p27 antibody levels compared with matched controls. When stratified by early versus established RA, participants with early RA had median IgG anti-Pc-p27 antibody levels that were overall higher, whereas median IgA anti-Pc-p27 antibody levels were statistically significantly higher in participants with established RA compared with their matched controls. In the autoantibody-specific analyses, the at-risk population with anti-cyclic citrullinated peptide (anti-CCP) antibodies, but not rheumatoid factor (RF), trended toward increased levels of IgG anti-Pc-p27. Additionally, RA participants who were seropositive for both CCP and RF had significantly increased levels of IgA anti-Pc-p27 antibodies and trended toward higher levels of IgG anti-Pc-p27 antibodies compared with matched controls.
Our findings support a potential etiologic role for P copri in both RA preclinical evolution and the subsequent pathogenesis of synovitis.
共生菌Prevotella copri(P copri)已被报道为类风湿关节炎(RA)患者的免疫相关生物。本研究旨在评估我们的参与者队列中的抗 P copri(anti-Pc)抗体反应,并确定这些反应在 RA 的自然病史中何时发生。
我们分析了处于发生 RA 风险中的研究参与者、发展为 RA 的参与者、早期 RA(<1 年疾病)的参与者和已确诊 RA 的参与者的血清中 27-kd P copri 蛋白(anti-Pc-p27)的免疫球蛋白 A(IgA)和 IgG 抗体水平,并与匹配的对照进行了比较。我们还评估了根据 RA 相关自身抗体状态分层的个体的抗-Pc-p27 抗体水平。
总体而言,与匹配的对照相比,RA 患者的 IgA 抗-Pc-p27 抗体水平显著升高,且 IgG 抗-Pc-p27 抗体水平也呈升高趋势。当按早期与已确诊的 RA 分层时,与早期 RA 相比,早期 RA 患者的 IgG 抗-Pc-p27 抗体水平总体较高,而与匹配的对照相比,已确诊 RA 患者的 IgA 抗-Pc-p27 抗体水平具有统计学意义。在自身抗体特异性分析中,具有抗环瓜氨酸肽(anti-CCP)抗体但无类风湿因子(RF)的高危人群的 IgG 抗-Pc-p27 水平呈升高趋势。此外,同时为 CCP 和 RF 阳性的 RA 患者的 IgA 抗-Pc-p27 抗体水平显著升高,且 IgG 抗-Pc-p27 抗体水平也呈升高趋势,与匹配的对照相比。
我们的发现支持 P copri 在 RA 临床前演变和随后的滑膜炎发病机制中具有潜在的病因作用。